Organoids research progress in gynecological cancers: a bibliometric analysis
This bibliometric analysis delineated global landscapes and progress trends in GC organoids research. This study emphasized that organoids can effectively replicate the original tissue or tumors, providing a good <i>in-vitro</i> model for research on tumor-related mechanisms and showing significant advantages in drug screening and efficacy clinical prediction. Additionally, as preclinical models, they provide compelling evidence for personalized therapy and prediction of patient drug responses.
Authors
- Hongbo Yu (ORCID: https://orcid.org/0000-0002-6808-1244)
- Haochuan Ma (ORCID: https://orcid.org/0000-0002-7663-120X)
- Dongmei Li (ORCID: https://orcid.org/0000-0003-3819-355X)
- Li Zhang (ORCID: https://orcid.org/0000-0002-3617-2627)
- Bing He (ORCID: https://orcid.org/0000-0001-5859-5754)
- Junjie Wang (ORCID: https://orcid.org/0009-0001-9328-5863)
Institutions
- China Three Gorges University (CN)
- Dalian Medical University (CN)
- First Affiliated Hospital of Dalian Medical University (CN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2024-10-28
- DOI
- https://doi.org/10.3389/fonc.2024.1484074
- Primary Topic
- Ovarian cancer diagnosis and treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China